July 13, 2015

Otsuka Pharmaceutical and H. Lundbeck A/S announced Friday that their new medication Rexulti (brexpiprazole) had been approved by the Food and Drug Administration as an adjunctive treatment for major depressive disorder (MDD) and a treament for schizophrenia. 

May 28, 2015

Camber Pharmaceuticals on Thursday announced that it had launched antipsychotic drug aripiprazole — a generic version of Abilify — in 2-, 5-, 10-, 15-, 20- and 30-mg dosage strength tablets. 

April 29, 2015

The Food and Drug Administration announced approval for the first generic versions of aripiprazole tablets.

April 29, 2015

Teva Pharmaceutical announced the launch of aripiprazole tablets in 2-, 5-, 10-, 15, 20- and 30-mg strengths in the United States.

March 1, 2013

The Food and Drug Administration has approved a once-monthly treatment for schizophrenia.

January 15, 2013

Drug maker Otsuka Pharmaceuticals can keep generic versions of its schizophrenia drug off the market, according to published reports.

May 8, 2012

A generic version of a schizophrenia drug made by Otsuka Holdings and Bristol-Myers Squibb can't be launched until April 2015, according to published reports.

February 3, 2012

Teva Pharmaceuticals has launched a generic version of a psychiatric drug, the company said Friday.

September 28, 2011

A new report from the Department of Health and Human Services' Agency for Healthcare Research and Quality found little evidence to support the use of atypical antipsychotic drugs for uses other than those for which they have official approval.

February 17, 2011

The Food and Drug Administration has approved a psychiatric drug for treating bipolar disorder when used in combination with one of two other drugs.

November 15, 2010

The U.S. District Court for the District of Delaware has upheld a patent held by...

August 10, 2010

The drug market for unipolar depression will get smaller over the next decade due to...